Published on 11 May 2023 on Simply Wall St. via Yahoo Finance
Cano Health, Inc. (NYSE:CANO) defied analyst predictions to release its quarterly results, which were ahead of market expectations. Results overall were solid, with revenues arriving 4.9% better than analyst forecasts at US$867m. Higher revenues also resulted in substantially lower statutory losses which, at US$0.12 per share, were 4.9% smaller than the analysts expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Cano Health after the latest results.
Check out our latest analysis for Cano Health
earnings-and-revenue-growth